INBP - Comprehensive Filing Intelligence

Q2 2026•10-Q•Filed Feb 11, 2026

4.0/10

Filing Health:CAUTION

Notable concerns that warrant closer review

Executive Summary

Revenue declined significantly in both segments, primarily due to reduced volumes from non-major customers and the loss of a major customer in the Other Business Lines Segment.. Margins are under pressure due to inflation, labor market tightness, and the inability to fully pass on increased costs to customers.. The company has ongoing lease obligations with a related party, Vitamin Realty Associates, LLC, whose ownership is tied to the former chairman's estate and family.. Overall net sales decreased by 8.6% for the six months ended December 31, 2025.

Top Concerns

!Revenue declined significantly in both segments, primarily due to reduced volumes from non-major customers and the loss of a major customer in the Other Business Lines Segment.
!Margins are under pressure due to inflation, labor market tightness, and the inability to fully pass on increased costs to customers.
!Negative cash flow conversion indicates poor earnings quality.
!Significant unvested stock compensation liability suggests future dilution risk.
!The company has ongoing lease obligations with a related party, Vitamin Realty Associates, LLC, whose ownership is tied to the former chairman's estate and family.

Top Positives

+Margins are under pressure due to inflation, labor market tightness, and the inability to fully pass on increased costs to customers.
+Operating results shifted from income to a loss, driven by lower sales and increased cost of sales as a percentage of revenue.
+Operating cash flow generation appears weak when excluding favorable working capital changes, though significant AR and inventory reductions improved reported cash flow.

Analysis Dimensions

Our 5-pass AI analysis examines this filing across multiple dimensions. Each dimension score is derived from direct analysis of SEC filing text.

Narrative Intelligence

5.0/10

Management tone is cautiously measured with focus on decrease in net sales in both segments impacting fixed manufacturing costs absorption..

Full analysis includes: tone changes vs prior quarter, margin driver breakdown, forward guidance analysis, strategic priorities.

Accounting Quality

4.0/10

Earnings quality shows aggressive accounting practices.

Full analysis includes: reserve and allowance changes, non-recurring item analysis, stock-based compensation impact, disclosure concerns.

Hidden Liabilities

Off-balance sheet risk is low.

Full analysis includes: cloud and purchase commitments, VIE/SPE exposure, covenant compliance status, refinancing risk assessment.

Risk Landscape

3.0/10

Overall risk profile shows customer concentration and loss as primary concern.

Full analysis includes: 8 risk categories with severity, new vs escalated risks, management response assessment, risk trend analysis.

Segment Performance

3.0/10

Segment health analysis shows Contract Manufacturing as strongest performer while Other Nutraceutical Business lags.

Full analysis includes: segment-by-segment revenue breakdown, geographic concentration risk, customer concentration analysis, segment margin trends.